Follow
Jiali Yan
Jiali Yan
Other namesJiali Helen Yan
Kite Pharma
Verified email at kitepharma.com
Title
Cited by
Cited by
Year
The Association Of A Sweetened Beverage Tax With Changes In Beverage Prices And Purchases At Independent Stores: Study compares changes in sweetened beverage prices and …
SN Bleich, HG Lawman, MT LeVasseur, J Yan, N Mitra, CM Lowery, ...
Health Affairs 39 (7), 1130-1139, 2020
542020
Subgroups of high-cost Medicare advantage patients: an observational study
BW Powers, J Yan, J Zhu, KA Linn, SH Jain, JL Kowalski, AS Navathe
Journal of general internal medicine 34, 218-225, 2019
372019
Unemployment claims in Philadelphia one year after implementation of the sweetened beverage tax
HG Lawman, SN Bleich, J Yan, MT LeVasseur, N Mitra, CA Roberto
PloS one 14 (3), e0213218, 2019
352019
Applying machine learning algorithms to segment high-cost patient populations
J Yan, KA Linn, BW Powers, J Zhu, SH Jain, JL Kowalski, AS Navathe
Journal of general internal medicine 34, 211-217, 2019
342019
Association of a Sweetened Beverage Tax With Purchases of Beverages and High-Sugar Foods at Independent Stores in Philadelphia
SN Bleich, CG Dunn, MJ Soto, J Yan, LA Gibson, HG Lawman, N Mitra, ...
JAMA Network Open 4 (6), e2113527-e2113527, 2021
312021
One-year changes in sugar-sweetened beverage consumers’ purchases following implementation of a beverage tax: a longitudinal quasi-experiment
HG Lawman, SN Bleich, J Yan, SV Hua, CM Lowery, A Peterhans, ...
The American Journal of Clinical Nutrition 112 (3), 644-651, 2020
292020
Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial
I Barankay, PP Reese, ME Putt, LB Russell, G Loewenstein, D Pagnotti, ...
JAMA Network Open 3 (10), e2019429-e2019429, 2020
232020
No Evidence of Food or Alcohol Substitution in Response to a Sweetened Beverage Tax
LA Gibson, HG Lawman, SN Bleich, J Yan, N Mitra, MT LeVasseur, ...
American journal of preventive medicine 60 (2), e49-e57, 2021
222021
Sustained Impact of the Philadelphia Beverage Tax on Beverage Prices and Sales Over 2 Years
J Petimar, LA Gibson, J Yan, SN Bleich, N Mitra, ML Trego, HG Lawman, ...
American journal of preventive medicine 62 (6), 921-929, 2022
192022
The Beneficial Effects Of Medicare Advantage Special Needs Plans For Patients With End-Stage Renal Disease: Study compares use and costs for patients with end-stage renal …
BW Powers, J Yan, J Zhu, KA Linn, SH Jain, J Kowalski, AS Navathe
Health Affairs 39 (9), 1486-1494, 2020
162020
Effect of Escalating Financial Incentive Rewards on Maintenance of Weight Loss: A Randomized Clinical Trial
WS Yancy, PA Shaw, C Reale, V Hilbert, J Yan, J Zhu, AB Troxel, ...
JAMA network open 2 (11), e1914393-e1914393, 2019
162019
3-Year Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
SS Neelapu, J Chavez, AR Sehgal, N Epperla, M Ulrickson, E Bachy, ...
Blood 140 (Supplement 1), 10380-10383, 2022
142022
Countermarketing About Fruit Drinks, Alone or With Water Promotion: A 2019 Randomized Controlled Trial in Latinx Parents
J Krieger, T Kwon, R Ruiz, LP Walkinshaw, J Yan, CA Roberto
American journal of public health 111 (11), 1997-2007, 2021
112021
The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: Rationale, design and methodologies
ME Putt, PP Reese, KG Volpp, LB Russell, G Loewenstein, J Yan, ...
Clinical Trials 16 (4), 399-409, 2019
112019
A machine learning approach to identify distinct subgroups of veterans at risk for hospitalization or death using administrative and electronic health record data
RB Parikh, KA Linn, J Yan, ML Maciejewski, AM Rosland, KG Volpp, ...
PloS one 16 (2), e0247203, 2021
102021
Qualitative Exploration of Barriers to Statin Adherence and Lipid Control: A Secondary Analysis of a Randomized Clinical Trial
I Barankay, PP Reese, ME Putt, LB Russell, C Phillips, D Pagnotti, ...
JAMA Network Open 4 (5), e219211-e219211, 2021
82021
Real-World Outcomes of Brexucabtagene Autoleucel (Brexu-cel) for Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A CIBMTR Subgroup Analysis of High-Risk Characteristics
S Kambhampati, N Ahmed, M Hamadani, S Kim, MT Hemmer, NS Grover, ...
Blood 142, 107, 2023
32023
Purchases of Non-taxed Foods, Beverages, and Alcohol in a Longitudinal Cohort after Implementation of the Philadelphia Beverage Tax
AH Grummon, CA Roberto, HG Lawman, SN Bleich, J Yan, N Mitra, ...
The Journal of nutrition, 2021
32021
3-Year Follow-up Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
SS Neelapu, JC Chavez, AR Sehgal, N Epperla, ML Ulrickson, E Bachy, ...
2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023
22023
Effect of Financial Incentives for Process, Outcomes, or Both on Cholesterol Level Change: A Randomized Clinical Trial
PP Reese, I Barankay, M Putt, LB Russell, J Yan, J Zhu, Q Huang, ...
JAMA network open 4 (10), e2121908-e2121908, 2021
22021
The system can't perform the operation now. Try again later.
Articles 1–20